0001179110-20-007740.txt : 20200623
0001179110-20-007740.hdr.sgml : 20200623
20200623204215
ACCESSION NUMBER: 0001179110-20-007740
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200621
FILED AS OF DATE: 20200623
DATE AS OF CHANGE: 20200623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chapman Steven Leonard
CENTRAL INDEX KEY: 0001711968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 20983599
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
edgar.xml
FORM 4 -
X0306
4
2020-06-21
0
0001604821
Natera, Inc.
NTRA
0001711968
Chapman Steven Leonard
C/O NATERA, INC., 201 INDUSTRIAL ROAD
SUITE 410
SAN CARLOS
CA
94070
1
1
0
0
Chief Executive Officer
Common Stock
2020-06-21
4
M
0
1117
A
26415
D
Common Stock
2020-06-22
4
M
0
181
A
26596
D
Common Stock
2020-06-22
4
M
0
3125
A
29721
D
Common Stock
2020-06-22
4
S
0
558
46.47
D
29163
D
Common Stock
2020-06-22
4
M
0
31250
13.01
A
60413
D
Common Stock
2020-06-22
4
S
0
4753
43.8869
D
55660
D
Common Stock
2020-06-22
4
S
0
28496
45.0727
D
27164
D
Common stock
2020-06-22
4
S
0
5547
46.0360
D
21617
D
Common Stock
2020-06-23
4
S
0
92
45.5113
D
21525
D
Common Stock
2020-06-23
4
S
0
1579
45.5102
D
19946
D
Restricted Stock Unit
2020-06-21
4
M
0
1117
0
D
Common Stock
1117
3352
D
Restricted Stock Unit
2020-06-22
4
M
0
181
0
D
Common Stock
181
2002
D
Restricted Stock Unit
2020-06-22
4
M
0
3125
0
D
Common Stock
3125
34375
D
Stock Option (right to buy)
13.01
2020-06-22
4
M
0
31250
0
D
2020-01-10
Common Stock
31250
131250
D
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 21, 2018.
Each RSU represents a contingent right to receive one share of the common stock of the issuer.
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 22, 2020.
The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.38 to $44.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.485 to $45.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.59 to $46.47 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.51 to $45.6274 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.51 to $45.5275 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter.
The RSUs vest over four years. 25% of the RSUs vest on March 22, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of June 8, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 62,500 additional shares.
/s/ Tami Chen, attorney-in-fact
2020-06-23